CannabisNewsBreaks Archive - Page 2 of 428

TuesdayNov 26, 2024 2:34 pm

CannabisNewsBreaks – CannabisNewsWire to Shine the Spotlight on 13th Annual MJBizCon

CannabisNewsWire (“CNW”), a leading communications platform for the cannabis industry and part of the InvestorBrandNetwork (“IBN”), today announced its engagement as the official newswire for the 13th Annual MJBizCon. In its 13th year, MJBizCon has firmly established itself as a flagship event, attracting over 30,000 cannabis executives, entrepreneurs and professionals annually from around the globe. Set to take place at the Las Vegas Convention Center from Dec. 3–6, 2024, this year’s event promises to continue its legacy as the premier global cannabis business conference and tradeshow. “MJBizCon is one of the most prestigious events in the cannabis industry, providing unparalleled…

ThursdayNov 21, 2024 11:30 am

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Host Spaces Event, Share Comprehensive Update on Destino Ranch

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call at 1:30 p.m. PST on Wednesday, Dec. 11, 2024, on the company’s official X account, @GTV_Inc. Steffan Dalsgaard, president of Golden Triangle Ventures and CEO of Lavish Entertainment, alongside Marco Moreno, president of Lavish Entertainment, will lead the event and deliver a comprehensive update on the company’s transformative flagship project — Destino Ranch. GTV’s wholly owned subsidiary Lavish Entertainment is spearheading the development of Destino Ranch, which is poised to become a world-renowned destination and premier experiential hospitality and entertainment venue, including immersive art installations,…

TuesdayNov 19, 2024 9:50 am

CannabisNewsBreaks – MJBizCon Partners with Voice of the Plant to Showcase Cannabis Genetics at “The Vault” Pavilion

Cannabis industry leader MJBizCon is putting genetics center stage at its December 2024 Las Vegas convention through a new partnership with Voice of the Plant. The collaboration will feature "The Vault" Pavilion, bringing together renowned breeders and cannabis genetics companies from around the world. Led by Mario Guzman, creator of the popular Gelato and Sunset Sherbert strains, and Victorine Deych of terpene company Dusted, the pavilion will host industry veterans including Amsterdam's Sensi Seeds, Barneys Farm, and leading U.S. genetics companies. The initiative aims to refocus attention on cannabis genetics as the foundation of the industry. "Sometimes in the excitement…

ThursdayOct 24, 2024 12:45 pm

CannabisNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry

CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70 billion industry and, with its innovative product line and strategic market positioning, standing ready to deliver unparalleled returns for shareholders. “The U.S. is on the verge of a historic shift. With the Biden administration, led by Vice President Kamala Harris, taking bold steps toward federal marijuana legalization, the opportunities for companies in the cannabis and CBD sectors are poised to skyrocket,” the announcement reads. “According to industry projections, the legal cannabis market in the U.S. is expected to surpass $70 billion by 2028, driven by…

WednesdayOct 16, 2024 12:20 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Subsidiary Negotiating Pharma Cannabis Supply Deal with Australian Firm

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, today announced that its Colombian subsidiary is in negotiations with an Australian pharmaceutical company to supply medical-grade cannabis. The agreement is expected to generate between $100,000 and $200,000 in monthly revenue once operations begin. MedCana's CEO, Jose Gabriel Diaz, emphasized the significance of this deal in the company’s ongoing global expansion aimed at meeting the rising demand for high-quality cannabis products. To view the full press release, visit https://cnw.fm/nJ6FT About Software Effective Solutions Software Effective Solutions/MedCana is a holding company…

WednesdayOct 09, 2024 12:35 pm

CannabisNewsBreaks – Software Effective Solutions Corp. (d/b/a MedCana) (SFWJ) Releases Report on Series of Acquisitions, Multiple Cannabis Licenses

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, is reporting on recent acquisitions and cannabis licenses associated with the acquisitions. According to the announcement, the new acquisitions and licenses, which will add $1.6 million to company assets for the third quarter, are designed to bolster the company's cannabis portfolio globally and solidify its position as a leading force in the cannabis sector. According to the announcement, the licenses include seven produce, process and sell CBD licenses; seven produce, process and sell THC licenses; seven fabrication of products containing…

FridaySep 27, 2024 3:20 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that it had received approval from an independent review board for its planned human pilot study #3. The approval signals that the company can begin the study, which aims to investigate the first ever DehydraTECH-processed version of tirzepatide, a dual action glucagon-like peptide (“GLP-1”) + glucose-dependent insulinotropic peptide (“GIP”), in an oral dose format. Tirzepatide is approved for use in the U.S. under the Eli Lilly(TM)-owned Zepbound(R) and Mounjaro(R) brands. Lexaria plans to begin subject enrollment shortly, with the company expecting to make an announcement as…

FridaySep 27, 2024 11:20 am

CannabisNewsBreaks – Grow Up Conference and Expo Engages CannabisNewWire as a Gold Sponsor, Official Newswire for Upcoming Event

Grow Up Conference and Expo, a Canadian-owned and operated leader in the cannabis industry, has engaged CannabisNewWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 60+ brands powered by InvestorBrandNetwork (“IBN”), to serve as a Gold Sponsor and Official Newswire for its upcoming industry-flagship event. The event is scheduled for September 29, 2024, to October 1, 2024, at the Edmonton Convention Center in Edmonton, Alberta. It brings together retail and wholesale buyers in Canada and boasts an insightful agenda that includes 100+ exhibitors, 50+ interactive sessions, and 80+ distinguished speakers, industry veterans, pioneers, and thought…

ThursdaySep 26, 2024 11:40 am

CannabisNewsBreaks – CannaCon Midwest to Help Drive Business, Accelerate Growth of Cannabis Industry Throughout the Midwest

CannaCon, a leading conference company, today announced that it will host the CannaCon Midwest Cleveland. Scheduled for October 3-4, 2024, the event will be held at the Huntington Convention Center in Cleveland, Ohio. The highly anticipated two-day event is a must-attend for entrepreneurs, founders, growers, dispensary owners, seed investors, medical professionals, policy experts, government regulators, and seasoned industry players. The event is expected to fulfill every cannabis business need throughout the value chain, from seed investments, cultivation supplies, and breakthrough tech innovations to first-rate legal and business advice, world-class genetics, and the sale of extraction equipment and retail displays. CannaCon…

FridaySep 20, 2024 3:54 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) technology. “Lexaria has recently made strides with glucagon-like peptide-1 (‘GLP-1’) studies. It has reported positive interim results from an animal study on diabetes. This milestone best showcases the potential of its patented technology in not only addressing diabetes and obesity. Recently, the company announced the dosing completion of its human pilot study #2, GLP-1-H24-2, which sought to explore effective oral delivery of GLP-1 drugs. Some evaluated aspects included side effects, blood levels of…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks